FDA Approves Red Blood Cell Storage Solution

by U.S. Medicine

June 17, 2013

WASHINGTON—A new red blood cell storage solution has recently been approved by the FDA.

Hemerus Medical LLC and its partner U.S. Army Medical Materiel Development Activity (USAMMDA), received approval of the New Drug Application for its SOLX System (LEUKOSEP HWB-600-XL Leukocyte Reduction Filtration System for Whole Blood with CPD Anticoagulant and SOLX Additive). It is the first red blood storage solution to be approved by FDA in more than 15 years, according to USAMMDA.

This system is already approved in Europe for eight-week red blood cell storage and has been approved by FDA in the United States for six-week red blood cell storage.

The development of the product was prompted by calculations showing that an additional two weeks of storage time could save DoD millions of dollars in transportation costs and decreased product loss due to product expiration during military deployments, a USAMMDA statement explained. It was also realized that “longer storage time only occurred with better quality cells.”

“This then was the genesis of a fruitful collaboration between the Army and academia, resulting in a number of peer-reviewed publications that proved the initial concept,” Victor Macdonald, product manager and blood products subject matter expert for Pharmaceutical Systems Project Management Office (PSPMO) at USAMMDA, said in a written statement. “After years of effort, a partnership was formed with industry for further development of the storage solution and incorporation into a blood collection system with commercial potential.”   

According to USAMMDA, the future for this product includes “implementing a Low Rate Initial Production contract where the Army Blood Program Office can purchase the SOLX product and obtain the subsequent military blood bank Biologic License Application approvals for the plasma and red blood cells, so they can begin using the system.”


Related Articles


U.S. Medicine Recommends


More From uncategorized

Uncategorized

White Patients Have Higher Mortality Risks from Heart Failure

WASHINGTON — In the last decade, the development of multiple molecular-targeted therapies has dramatically altered the treatment landscape for advanced renal cell carcinoma (RCC). The rate of new drug approvals has outpaced the ability of... View Article

Uncategorized

GAO: VA, DoD ‘Years Away’ From EHR Interoperability

WASHINGTON — In the last decade, the development of multiple molecular-targeted therapies has dramatically altered the treatment landscape for advanced renal cell carcinoma (RCC). The rate of new drug approvals has outpaced the ability of... View Article

Uncategorized

Do you think VA facilities need to be closed for cost-saving reasons?

WASHINGTON — In the last decade, the development of multiple molecular-targeted therapies has dramatically altered the treatment landscape for advanced renal cell carcinoma (RCC). The rate of new drug approvals has outpaced the ability of... View Article

Uncategorized

Do you think VA physicians prescribe too many unnecessary antibiotics?

WASHINGTON — In the last decade, the development of multiple molecular-targeted therapies has dramatically altered the treatment landscape for advanced renal cell carcinoma (RCC). The rate of new drug approvals has outpaced the ability of... View Article

Uncategorized

VA Lags on Women’s Health; No Gynecologists at Some VAMCs

WASHINGTON — In the last decade, the development of multiple molecular-targeted therapies has dramatically altered the treatment landscape for advanced renal cell carcinoma (RCC). The rate of new drug approvals has outpaced the ability of... View Article

Facebook Comment

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up